Onex Canada Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Onex Canada Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-70,775	Closed	-$4.87M	–	100
2015 Q4	$4.87M	Buy	70,775 +24,720	+54%	+$1.63M	0.35%	37
2015 Q3	$2.04M	Buy	+46,055	New	+$2.92M	0.2%	44

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Onex Canada Asset Management's BMY Position: Q1 2016 in Review

Onex Canada Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 70,775 shares — an estimated $4.87M sold.

Onex Canada Asset Management first reported a position in BMY in Q3 2015 and held it in 2 quarters. The position peaked at $4.87M in Q4 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Onex Canada Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
Onex Canada Asset Management sold 70,775 Bristol-Myers Squibb shares in Q1 2016, an estimated $4.87M.
Onex Canada Asset Management first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 2 quarters.
Onex Canada Asset Management's Bristol-Myers Squibb position peaked at $4.87M in Q4 2015.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Onex Canada Asset Management's 13F filing for Q1 2016, filed 14 Apr 2016.